Author

Pradip Bajgain

Baylor College of MedicineORCID 0000-0002-4719-8451Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

Alejandro G. Torres ChaveziD· 1 shared Anandani NellaniD· 1 shared Anmol Gupta· 1 shared Ann Marie LeeniD· 1 shared Brad St. CroixiD· 1 shared Dan Li· 1 shared Guojun YuiD· 1 shared Jaewon Lee· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alejandro G. Torres ChavezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineering Functionality-Optimized Fully Human B7-H3 CAR T Cells for Enhanced Solid Tumor Therapy

Pradip Bajgain, Yang Feng, Mariela Puebla, Meijie Tian, Kuo-Sheng Hsu, Jaewon Lee, Guojun Yu, Liping Yang, Steven Seaman, Mary Beth Hilton, Karen Morris, Niza Borchin, Jennifer D. Tran, Riley D. Metcalfe, Dan Li, , Brad St. Croix

This study develops fully human B7-H3 CAR T cells using phage display, showing improved antitumor activity and reduced immune response in xenograft models.

Cell Reports Medicine · May 1, 2026Peer-reviewedImmunology

IL-7 armed binary CAR T cell strategy to augment potency against solid tumors

Alejandro G. Torres Chavez, Mary Kathryn McKenna, Anmol Gupta, Neha Daga, Juan F. Vera, Ann Marie Leen, Pradip Bajgain

This study develops a binary CAR T cell strategy targeting PSCA and MUC1 with IL-7 expression to improve antitumor potency and persistence in pancreatic tumors.

Frontiers in Immunology · Jul 30, 2025Peer-reviewedImmunology